MY ANALYSIS OF TODAY’S EVENTS, DOT CONNECTING, AND NUMBER

New Post Public Reply Private Reply Replies (4) Message Board
Trazbull
MY ANALYSIS OF TODAY’S EVENTS, DOT CONNECTING, AND NUMBER CRUNCHING:

Ok Folks….KOOS really came through today in a HUGE way for not only us longs, but for the future of the company(s) in general, not to mention throwing a major wrench in the plans of ANY planned or existing shorters of the stock.
On the latter first off, the Regen stock dividend to BMSN shareholders of record as of a date in the very near term, yet to be determined, will cost them a pretty penny to have to pay those that are long the stock if they even can. When one goes short and there is a dividend, the shorters must PAY a dividend to those that are long. In this case of a stock dividend, they do not pay cash but rather must pay shares of REGEN stock to the longs. How can they do this as a) there currently have NO shares of REGEN stock available to be paid, and b) they would have to buy the REGEN stock on the market (or borrow it) to make said payment. They will not be able to fulfill this obligation and, as such, will have to wait until REGEN becomes a free trading ticker to acquire the shares to then pay to the longs. In reality this is not practical or feasible in the near terms as the O/S for REGEN at the time of the dividend issuance is 51.6M shares in total, with almost if not 100% of them outside the float. In a nutshell, this divvy maneuver alone should force whatever shorts there are in BMSN to cover prior to the soon to be announced Ex-Dividend date.

I am going to save my financial analysis of this transaction for the end, and jump right into the recent past (from 8k’s over the past month or so) and today’s 1-2 punch PR and 8k. It is 100% clear to me that management has created a full on new corporate structure that accomplishes a few fantastic goals…it sets up the company(s) to be much healthier from a shareholder and operational perspective going forward as well as effectively flushing the past down the toilet. Regen is the golden goose and has now been placed as such in the new corporate structure. BMSN for all intents and purposes is now nothing more than a 58.15% owner of REGEN with us longs being a roughly 38.75% direct owner. Going forward, REGEN will be the primary entity and the only entity generating value…management, by taking REGEN public, is assuring that avenue opens to them. BMSN will continue to reap the benefits as well, though their direct ownership of REGEN (which again will be at 58.15% or so as of the date of the public filing). This also provides for a FRESH and 100% clean share structure to move forward with, unlike that of BMSN currently…..being able to realize and unlock much more shareholder value than in the current BMSN share structure with all its prior worts. Another part of the beauty here is that all the toxic crap in BMSN (albeit much less than there was), stays in BMSN and does not in any way impede the natural and potentially booming progress that REGEN can and will make. I do foresee some further dilution of BMSN shares for the current toxics not yet converted, and it can also serve as a financing vehicle for REGEN that will NOT impact REGEN’s share structure directly. It could and will affect the shares we own directly in BMSN, however it will be more than mitigated by unlocking the true value of REGEN currently and over time….IMO, just ingenious!

NOW LET’S TALK THE NUTS AND BOLTS OF THE TRANSACTION(S): First off, I was completely ecstatic (for all the reasons outlined above concerning shorts and company strategy and share structure going forward) to read the PR that came out at 3:11pm today on its own. It made me start crunching numbers to see what it would all mean, and I was left with 1 monster question…VALUATION!!! Then shazam, that question was answered with the 8K issued at 3:45pm today….the old 1, 2 punch!
Here is how the DIVY will affect all of us longs….As stated in the PR, all common and preferred shareholders will be receiving, pro-rata, 20M shares of REGEN as of an ex-dividend date to be determined shortly. Per a call made to the TA today that I got from another post, the common O/S is about 2.393B (no change folks), and the preferred shares O/S as of the June 30 10Q were approximately 2.9M. So for ease and purposes of my math, assume the total O/S is at 2.5B shares. 20M shares dividend would result in 8,000 shares of REGEN for every 1Million shares owned of BMSN on the ex-date. Regen is also filing an S-1 registration statement to go public, and REGEN will then become free trading when this goes effective. Current BMSN longs will own 38.75% (20M shares) of Regen, BMSN will own 58.15% (30,010,000 shares) of REGEN and other holders will own the remaining 1.6M shares of REGEN (1.5 of which are owned by Caven Investments per the 8k filed on 9/9/13 per agreement dated 8/26/13 (THESE DATE ARE IMPORTANT!!). After the Dividend ALL CURRENT BMSN SHAREHOLDERS WILL STILL OWN THE SAME NUMBER OF BMSN SHARES THEY CURRENTLY OWN AS WELL.

This all sounded great, but the next question I had was what price would REGEN be valued and how would that valuation be determined. The 8K at 3:45 answered that question. In that filing today, an entity (ASC Recap, LLC) was repaid a $100k loan for 100,000 shares of REGEN…$1 a share!!!!!! This tells me that the $1 a shares is at least the current valuation of REGEN on its own as verified by a third party transaction. It could be more even as these types of transactions are typically and often done at a discount (as we have seen). As the Caven transaction for REGEN shares happened at the end of August, it is perfectly clear to me that taking REGEN public was in the works by at least that time if not before…bringing the possible go-public date as soon as 4-6 weeks from now, and maybe sooner.

Based on the all the above, assume you have 1Million BMSN shares and the $1 REGEN valuation is correct. On the ex-date, you would then own 8,000 shares of REGEN and 1 Million shares of BMSN. The Regen direct shares would be worth $8,000 and the BMSN shares would be worth $.012 a share or $12,000….or your current 1M BMSN shares at .002 close today valued at $2,200 would now altogether have a $20,000 value! I get the $.012 value for BMSN based solely on its pass-through ownership of REGEN with a valuation of $51.6Million ($1 x the 51.6Million shares outstanding) and BMSN will own 58.15% of REGEN or an asset worth about $30Million. Divide that by 2.5Billion shares and you get $.012 for BMSN shares…..THIS IS CALLED UNLOCKING SHAREHOLDER VALUE!

This all also tells me that the Hema IND is close and that the MIN IND filing is about to happen, this the roughly $50M valuation that has already been transacted upon with REGEN….easy to connect those dots as REGEN would not be worth anything near that if things were about to come to fruition.

RIVULET MEDIA INC. (RIVU) Stock Research Links

RIVU Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Main Street Merger Faces Scrutiny: What It Means for Shareholders

Updated Category News Views 51

Under the Radar, but Not for Long Ah, mergers—those grand gestures in corporate America that promise growth, synergy, and shareholder value. But not every deal is a head-turner; some fly under the radar until someone grabs the magnifying glass. And that's exactly what's happening with Main Street Financial Services Corp.'s (OTC: MSWV) proposed merger with First...

Continue Reading
BAIC FOTON Eyes Africa for Bold Expansion Moves

Updated Category News Views 121

Pushing the Pedal to the Metal in Africa So here's the thing. When a company like BAIC FOTON sets its sights on Africa, you best believe they're not just twiddling their thumbs. Coming off a strong streak in the commercial vehicle game—topping China's sales for 21 years and exports for 15—their ambitions are now married to a keen interest in Africa's burgeoning...

Continue Reading
TCL Powers Senegal's Youth Olympics with Solar Display

Updated Category News Views 114

Innovative Display Tech Lands in Senegal Cutting through the noise of corporate clutter, TCL just made a move in Senegal that's got layers deeper than a PR stunt. They’ve handed over an ultra-low-power display system to the Université Amadou Mahtar Mbow (UAM) in Dakar, which is also moonlighting as the Youth Olympic Village for the 2026 Games. This isn't just any...

Continue Reading
Millrose Properties Faces Legal Storm: Investors Alerted

Updated Category News Views 187

Millrose Properties: A Storm's Brewing Whoa, step back and take a wide-eyed look at Millrose Properties—there’s a storm brewin’ and it’s a doozy! Right now, they’re up against one mighty class action lawsuit, and investors who’ve been hit for over $100k better circle December 8, 2026, on their calendars if they fancy a shot at lead plaintiff glory. We’re...

Continue Reading
ScienceOra Unveils AI Catalyst Design at Tencent Summit

Updated Category News Views 110

AI in Material Science: Beyond Buzzwords There's a lot of talk out there about AI changing the world, but it's always a different tune when it's put under a microscope. At the 2026 Tencent Global Digital Ecosystem Summit, ScienceOra and Wenge AI showcased an AI-assisted workflow for designing hydrogen-production catalysts. This isn't your average AI cheerleading session,...

Continue Reading
SAMILBIO Gambles on 'Chaeyun' Launch With November Events

Updated Category News Views 25

Can SAMILBIO's New Products Make a Splash? In a world where skincare is more competitive than a hot dog stand outside a vegan festival, here comes SAMILBIO with their latest offerings. Launching a whitening cream and an acne-fighting gel under the 'Chaeyun' brand, this company isn't just sticking to digital—it's diving into face-to-face consumer interaction. I mean,...

Continue Reading
HanAll F&B Pioneers New Path for Domestic Rice Noodles

Updated Category News Views 173

New Spin on an Old Favorite: Rice Noodles Forget about the same old wheat noodles clogging up the pantry. HanAll F&B is revamping the noodle game with a homegrown twist, setting sights on a future where Korean rice isn't just for steaming, soup, or sushi. This outfit from Taebaek, Gangwon, has got its hands deep in the rice flour, finessing a patent that aims to make...

Continue Reading
Duolingo Investors Must Weigh Legal Options Now

Updated Category News Views 141

Pressure Mounts on Duolingo Amid Legal Turmoil Well, here's a riddle solved with a lawsuit: when an app's growth hits the brakes, the lawyers seem to get moving fast. It seems like Duolingo, Inc. (NasdaqGS: DUOL) is learning a harsh lesson—not exactly in Spanish or French, but in the courtroom. They've been slapped with a securities class action, and it ain't looking...

Continue Reading
SCANOLOGY's AirGO Pad Revolutionizes On-Site Inspections

Updated Category News Views 152

Mobile 3D Scanning — Finally, Some Real Innovation Gone are the days where engineers had to cart around bulky laptops just to finish a simple inspection. SCANOLOGY has thrown a real game-changer into the mix with their new AirGO Pad. It's essentially a slick tablet that keeps your scanning, inspecting, and reporting all in one place, right beside whatever tangled hunk...

Continue Reading
Everest Group Faces Class Action: Key Deadlines Looming

Updated Category News Views 138

Everest Group's Legal Quagmire: A Rocky Road Ahead Riding high has its pitfalls. I mean just take a gander at Everest Group, Ltd. (NYSE: EG). The suits and stocks got their knickers in a twist when the company's missteps saw them landing smack dab in the middle of a shareholder class-action lawsuit. It's gloomy days, my friend, especially if you're carrying a portfolio...

Continue Reading

Top 5 Most Recently Viewed Articles

Palatin Technologies Works to Resolve NYSE Compliance Issues

Updated Category News Views 122

Palatin Technologies Faces NYSE Compliance Challenges Palatin Technologies, Inc. (NYSE American: PTN) has encountered a significant hurdle in maintaining its listing on the NYSE American. The biopharmaceutical company focuses on developing innovative medications that target the melanocortin receptor system, which plays a crucial role in various health conditions....

Continue Reading
IDrive® e2 Integrates AWS STS for Enhanced Cloud Security

Updated Category News Views 178

IDrive® e2 Integrates AWS STS for Enhanced Cloud Security IDrive® e2, a leading provider of S3-compatible cloud object storage, is proud to announce the support for AWS Security Token Service (STS). This significant enhancement is set to revolutionize how users manage access to their cloud storage. This new feature provides temporary and limited-privilege credentials,...

Continue Reading
Increased Benefits: PG&E Expands Electric Rate Discounts

Updated Category News Views 274

Expanded Discount Eligibility for PG&E Customers Customers are encouraged to verify their eligibility and apply for the advantageous monthly electric discount. The program has expanded significantly, allowing more than 150,000 additional Pacific Gas and Electric Company (PG&E) customers to qualify for an impressive 18% discount on their electric rates. Known as the Family...

Continue Reading
Key Information for XPLR Infrastructure Investors: Define Your Rights

Updated Category News Views 178

Understanding the Current Situation for XPLR Infrastructure Investors The investment landscape can often be tricky to navigate, especially when it comes to understanding the rights and potential claims associated with various securities. This is particularly true for investors of XPLR Infrastructure, LP, formerly known as Nextera Energy Partners, LP, who have found...

Continue Reading
TRIMEDX Expands Leadership Team to Drive Innovation Forward

Updated Category News Views 351

TRIMEDX Enhances Leadership Team for Future Growth TRIMEDX, a prominent name in the clinical asset management landscape, is making significant strides to bolster its leadership team. By welcoming two new executives and promoting a senior member, the company aims to advance its commitment to delivering excellence in clinical engineering services and innovations in medical...

Continue Reading